Citations

Clear

1152 citation(s) found for "Todd, A".

Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study (P8-15.018)
Lipton, Richard, Goadsby, Peter; id_orcid 0000-0003-3260-5904, Pozo-Rosich, Patricia, Schwedt, Todd, Fanning, Kristina, Abraham, Lucy, Blakeman, Karin Hygge , Urani, Alexandre , Lambru, Giorgio , Pozo‐Rosich, Patricia , Schwedt, Todd J. , Fanning, Kristina M. , Dai, Feng , Abraham, Lucy

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215441 Get It

The Effects of Medical Comorbidities and Patient Demographics on Migraine Preventive Medication Selection and Treatment Outcomes (P2-15.006)
Dumkrieger, Gina, Cutrer, F. Michael, Schwedt, Todd, Ihara, Keiko , Dumkrieger, Gina , Cutrer, F. Michael , Schwedt, Todd J. , Chiang, Chia‐Chun

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215014 Get It

Brain Functional Connectivity Correlates of Pain Catastrophizing in Post-traumatic Headache (S23.002)
Chong, Catherine, Nikolova, Simona , Dumkrieger, Gina, Leonard, Michael, Smith, Dani, Schwedt, Todd, Bighiani, Federico , Dumkrieger, Gina , Schwedt, Todd J.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000213284 Get It

Indocyanine Green Fluorescence for Intraoperative Tumor Identification During Resection of Pediatric and Adolescent Intra-Abdominal Malignancy: A Prospective Multi-Institutional Observational Study
Schermerhorn, Sophia MV, Dasgupta, Roshni, Jenkins, Todd , Kastenberg, Zachary, Piché, Nelson , Roach, Jonathan P. , Rhee, Daniel S. , Tracy, Elisabeth T., Davies, Dafydd A., Boehmer, Chloé, Bondoc, Alexander , Tracy, Elisabeth T. , Polites, Stephanie F. , Tracy, Elisabeth T , Hartman, Stephen J. , Dasgupta, Roshni , Lautz, Timothy B. , Kastenberg, Zachary J. , Malek, Marcus M. , Aldrink, Jennifer H. , Brown, Erin G. , Lal, Dave R. , Kim, Eugene S. , Le, Hau D. , Boehmer, Chloé

Mayo Clinic

Journal of the American College of Surgeons | June 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/xcs.0000000000002056 | PMID 42233485 Get It

Background: Real-time intraoperative discrimination of malignant tissue during pediatric solid tumor resection is limited, constraining margin optimization; the utility of indocyanine green (ICG) fluorescence in this population remains incompletely defined. Study Design: Prospective, observational, multi-institutional study (2019–2023) of pediatric, adolescent, and young adult patients undergoing resection of intra-abdominal solid malignancies following preoperative ICG administration. The primary endpoint was diagnostic accuracy of ICG fluorescence for tumor-containing specimens; secondary endpoints included association with margin status and surgeon-perceived intraoperative benefit. Results: Forty-three operations in 42 patients yielded 55 specimens, of which 47 (85%) were malignant. Diagnostic performance was highest in hepatic tumors (sensitivity 83%, positive predictive value 83%) and lower in adrenal and heterogeneous tumor types. ICG avidity was not associated with improved negative margin rates (86% vs 75%, p=0.47). Surgeons reported intraoperative benefit in 67% of cases, most commonly improved visualization. No ICG-related adverse events occurred. Conclusions: ICG fluorescence provides reliable tumor identification in hepatic malignancies but does not correlate with margin-negative resection, indicating limited utility for margin guidance. These data support tumor-specific application and further investigation of optimized fluorescence strategies, including dosing, timing, and alternative fluorophores, in pediatric oncologic surgery.
Indications and Outcomes of Non-Emergent Cardiac Surgery Following Transcatheter Aortic Valve Replacement
Schaff, Hartzell V, Greason, Kevin L. , Bagameri, Gabor, Dearani, Joseph A, Holst, Kimberly , Pochettino, Alberto, Arghami, Arman , Todd, Austin, Crestanello, Juan A, Schaff, Hartzell V. , Qamar, Younus , Schaff, Hartzell , Holst, Kimberly A, Pochettino, Alberto , Arghami, Arman , Dearani, Joseph A. , Pochettino, Alberto , Todd, Austin , Crestanello, Juan A.

Mayo Clinic

Interdisciplinary CardioVascular and Thoracic Surgery | June 1, 2026 | Volume: 41 | Issue: 7 | Pages: No page available

10.1093/icvts/ivag142 | PMID 42231119 Get It

Abstract Objectives This study examined the indications, frequency, and outcomes of cardiac surgery following transcatheter aortic valve replacement (TAVR) at a single institution. As TAVR volumes increase, understanding the nature and outcomes of subsequent cardiac operations is critical, particularly as the procedure expands to younger, lower-risk populations. Methods We analysed outcomes of 61 patients who underwent cardiac surgery after TAVR at our institution from August 2011 to September 2023, excluding periprocedural complications and staged procedures. Patients were stratified into 2 groups: those requiring surgical aortic valve replacement (SAVR) with or without concomitant procedures (n = 33) and those undergoing non-SAVR cardiac operations (n = 28). Data were collected from a prospectively maintained cardiovascular surgery database and electronic health records. Indications for surgery, operative characteristics, and outcomes were analysed, with survival assessed using Kaplan-Meier estimates. Results The median interval between TAVR and cardiac surgery was 19 months. Indications for SAVR included infective endocarditis (36%), non-structural valve deterioration (36%), structural valve deterioration (12%), and valve thrombosis (6%). Non-SAVR operations primarily addressed mitral valve disease (43%) and coronary artery disease (29%). Operative mortality was 6.6%, with no deaths in the endocarditis subgroup. Postoperative complications included prolonged mechanical ventilation (18%), new-onset renal failure (7%), and stroke (2%). Kaplan-Meier survival estimates were 83% at 1 year and 50% at 5 years. Conclusions Although complex, cardiac operations in patients who have undergone TAVR can be performed with acceptable mortality rates. Structural valve deterioration, paravalvular leak, and endocarditis were the primary indications for SAVR, while mitral valve and coronary artery disease predominated in non-SAVR cases. These findings highlight the importance of considering nonaortic valve pathologies in TAVR planning, particularly as the procedure expands to younger, lower-risk populations.
Rapid reduction in global chromatin loop size after acute STAG2 reconstitution in human cancer cells
Yang, Tianyi , Kim, Jung-Sik, Mellows, Clara , Xu, Wanying, Ya, Alvin , Sadzewicz, Lisa, Tallon, Luke, Sarkaria, Jann, Jin, Fulai, Waldman, Todd, Kim, Jung-Sik , Xu, Wanying, Sadzewicz, Lisa , Tallon, Luke J. , Sarkaria, Jann N. , Jin, Fulai , Waldman, Todd

Mayo Clinic

No container title available | May 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.26.727913 | PMID 42244697 Get It

ABSTRACT Truncating mutations in the tumor suppressor STAG2 , which encodes a component of the cohesin complex, are prevalent across diverse human cancers. Here, we report that acute reconstitution of physiological STAG2 levels in STAG2 -mutant human glioblastoma multiforme cancer cells triggers a rapid reduction in the size of chromatin loops genome-wide. Despite this global change in chromatin loop size, early transcriptional responses to STAG2 restoration are limited to a small number of genes, most of which are induced by STAG2 reconstitution. Notably, the growth-suppressor EFEMP1 (Fibulin-3), a secreted glycoprotein that functions as an extracellular matrix-associated inhibitor of glioblastoma growth and invasion, was the only gene consistently induced across all experimental models. The most robust and conserved STAG2-induced genes all reside within intense chromatin loops whose anchors and overall intensity did not appear to change in response to STAG2 reconstitution. These findings suggest that inactivating mutations of STAG2 promote neoplastic transformation by alleviating a restriction on chromatin loop size, allowing for an expanded range of chromatin interactions that disrupts the maintenance of a tumor-suppressive transcriptome.
Characterizing the Activity of Inflammasome‐Related Genes and Their Association With Oncological Outcomes in Prostate Cancer
Alshalalfa, Mohammed , Karnes, R Jeffrey, Purves, J. Todd, Hughes, Francis M., Abern, Michael R. , Ghoreifi, Alireza , Ghoreifi, Alireza , Davicioni, Elai , Spratt, Daniel E. , Karnes, R. Jeffrey, JT, Purves, Hughes, Francis M. , Moul, Judd W.

Mayo Clinic

The Prostate | May 26, 2026 | Volume: 86 | Issue: 11 | Pages: 1224-1232

10.1002/pros.70202 | PMID 42190028 Get It

ABSTRACT Background Inflammation plays a critical role in cancer cell proliferation; however, the specific role of inflammasomes, multiprotein complexes that regulate inflammation‐associated signaling pathways, in prostate cancer (PCa) remains insufficiently explored. This study aims to characterize the expression of inflammasome‐related genes in PCa and evaluate their association with clinical outcomes. Methods De‐identified transcriptome data from the Decipher GRID RP, a cohort of 52,266 radical prostatectomy (RP) samples tested (2016–2024) with the Decipher prostate genomic classifier (Veracyte, San Diego, CA), were retrieved from the GRID registry (NCT02609269). Expression analysis of 34 genes involved in inflammatory pathways was conducted to associate their expression with clinical and genomic variables. Outcomes analyses were conducted on a retrospective cohort of 855 patients treated with RP (META855). Results Analysis of inflammasome gene expression in the GRID RP cohort revealed that most genes exhibit low baseline expression, whereas HSP90AB1, APP, TXN, and TXNIP demonstrate strong expression signals. Additionally, higher expression of most genes was associated with Gleason Grade Group 4–5 and very high Decipher scores. On survival analysis of the META855 cohort, higher expressions of AIM2 and HSP90AB1 were significantly associated with worse metastasis‐free survival. Conversely, both high and low expression levels of NLRP3 were associated with better metastasis‐free survival outcomes following RP compared to average expression. On multivariable Cox regression analysis, higher expressions of AIM2 (HR 1.75) and HSP90AB1 (HR 1.60) were significantly associated with shorter time to metastasis following RP. Conclusions There is molecular heterogeneity within pro‐inflammatory genes among patients with PCa. Our findings showed there is a potential association between the expression levels of certain inflammasomes, such as AIM2, HSP90AB1, and NLRP3, and oncological outcomes following RP.
An Evaluation of Pediatric Dermatology Fellowship Websites: Content Analysis and Perspectives of Fellows and Program Directors
Huang, Cathleen , Iloabuchi, Vivian C. , Breinholt, Jacob, Starghill, Micah, Todd, Austin, Witt, Bryan, Pollock, Jordan R. , Chen, Joyce, Davis, Dawn Marie R. , Pollock, Jordan Riley , Starghill, Micah , Breinholt, Jacob , Witt, Bryan

Mayo Clinic

Pediatric Dermatology | May 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/pde.70271 | PMID 42186695 Get It

ABSTRACT Background/Objectives Prospective applicants for pediatric dermatology fellowships often use program websites as a source of information. This study evaluated the content of pediatric dermatology fellowship websites to identify potential areas of improvement including website accessibility and information found on websites. In addition, this study also surveyed current pediatric dermatology fellows and program directors (PDs) to determine priorities in website content across different stakeholders. Methods Using the Society for Pediatric Dermatology's (SPD) list of fellowship programs, two independent evaluators assessed the same 40 total programs, with 29 of the same websites included for analysis, against 27 criteria across four domains. In addition, an electronic survey was disseminated via the SPD's mailing list to current pediatric dermatology fellows and fellowship PDs. Results On average between both evaluators, of the 29 included fellowship websites, 9 educational criteria were included 47.8% of the time across the websites, compared to 46.0% of 10 recruitment criteria, 30.7% of 5 social criteria, and 31.6% of 3 other criteria. Fellows were significantly more likely than PDs to consider several website components as highly valuable. Conclusions These findings reveal variable and incomplete content across pediatric dermatology fellowship websites, as well as differing expectations for fellowship websites between pediatric dermatology fellowship applicants and PDs, which may help provide suggestions to optimize future website development to enhance applicant engagement.